AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.06 Decreased By ▼ -0.47 (-0.36%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.49 Decreased By ▼ -0.14 (-3.02%)
DCL 8.55 Decreased By ▼ -0.39 (-4.36%)
DFML 40.82 Decreased By ▼ -0.87 (-2.09%)
DGKC 80.96 Decreased By ▼ -2.81 (-3.35%)
FCCL 32.77 No Change ▼ 0.00 (0%)
FFBL 74.43 Decreased By ▼ -1.04 (-1.38%)
FFL 11.74 Increased By ▲ 0.27 (2.35%)
HUBC 109.58 Decreased By ▼ -0.97 (-0.88%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.31 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.72 Decreased By ▼ -0.68 (-8.1%)
MLCF 38.60 Decreased By ▼ -1.19 (-2.99%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 194.69 Decreased By ▼ -4.97 (-2.49%)
PAEL 25.71 Decreased By ▼ -0.94 (-3.53%)
PIBTL 7.39 Decreased By ▼ -0.27 (-3.52%)
PPL 155.45 Decreased By ▼ -2.47 (-1.56%)
PRL 25.79 Decreased By ▼ -0.94 (-3.52%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 78.65 Decreased By ▼ -3.79 (-4.6%)
TELE 7.86 Decreased By ▼ -0.45 (-5.42%)
TOMCL 33.73 Decreased By ▼ -0.78 (-2.26%)
TPLP 8.40 Decreased By ▼ -0.66 (-7.28%)
TREET 16.27 Decreased By ▼ -1.20 (-6.87%)
TRG 58.22 Decreased By ▼ -3.10 (-5.06%)
UNITY 27.49 Increased By ▲ 0.06 (0.22%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,445 Increased By 38.5 (0.37%)
BR30 31,189 Decreased By -523.9 (-1.65%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)
Editorials

Scientists close to HIV cure in humans after treating mice through gene-editing

In light of a recent breakthrough where scientists cured HIV via gene-editing in living animals, scientists now bel
Published July 4, 2019 Updated July 8, 2019

In light of a recent breakthrough where scientists cured HIV via gene-editing in living animals, scientists now believe that they are closer to finding a cure for HIV for humans too.

For the first time ever, researchers have cured HIV, the virus that leads to AIDS, from the genes of living mice through CRISPR gene-editing. This discovery marks as a great achievement along the path to freeing humans from the lethal disease.

The team started by engineering mice to create human T cells susceptible to HIV infection. After infecting the mice, the researchers used a therapeutic strategy called long-acting slow-effective release antiretroviral therapy (LASER ART) in order to suppress HIV replication within mice, reported Futurism.

Gene-editing tech could make people immune to flu, HIV in future

In the end, the team then used CRISPR gene-editing technology for removing HIV DNA from the infected cells. After later analyzing the animals, it was discovered that about one-third of the animals showed no signs of HIV.

Next, the team plans on combining LASER ART and CRISPR therapy in non-human primates. If those trials go successful, the human trials will initiate within the year, as per researcher Kamel Khalili. However, though optimistic, they do realize the hurdles they would have to cross.

“Things that work in mice, may not work in men,” researcher Howard Gendelman told CNBC. “The limitations of any mouse work have to do with the species, how the drug is administered, the distribution, which is a lot easier than a man or a woman.”

Copyright Business Recorder, 2019

Comments

Comments are closed.